Results 211 to 220 of about 1,346,069 (268)

In vitro models of microglia: a comparative study. [PDF]

Sci Rep
Woolf Z, Stevenson TJ, Lee K, Highet B, Macapagal Foliaki J, Ratiu R, Rustenhoven J, Correia J, Schweder P, Heppner P, Weinert M, Coppieters N, Park T, Montgomery J, Smith AM, Dragunow M.   +15 more
europepmc   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

TIM-1 and Tiny-TIM as Robust In Vitro Models for Oral Biopharmaceutics: Evidence from an International Ring Study. [PDF]

Pharmaceutics
O'Farrell C, Havenaar R, McAllister M, Hens B, Barker R, Mármol ÁL, Ansari A, Ooms T, Schilderink R, Schwabe R, Butler J, Stróžyk M, Martins Garcia T, Minekus D, Sarcevica I, Smith K, Tomaszewska I, Jones E, Batchelor H, Bellmann S.   +19 more
europepmc   +1 more source

Emerging in vitro models of corneal stromal fibrosis: Toward human-relevant platforms for anti-scarring therapeutics. [PDF]

Indian J Ophthalmol
Dereli Can G, Gurdal M, Barut Selver O.
europepmc   +1 more source

Post-Translational Modifications in Respiratory Virus Infection: Recent Insights into the Development of In Vitro Models. [PDF]

Int J Mol Sci
Ben Khlifa E, Campese A, Corsi A, Bombieri C, Romanelli MG, Valenti MT, Zipeto D, Castelli M, Lievens PM, Ruggiero A.   +9 more
europepmc   +1 more source

Computer models and artificial intelligence increase the fidelity and efficiency of the in vitro models for hearing loss. [PDF]

Biomed Eng Online
Iftode L, Danceanu CMZ, Cumpata AJ, Popa M, Labusca L, Radulescu L.   +5 more
europepmc   +1 more source

NLRP3 Inflammasome Inhibition Attenuates Diabetic Kidney Injury via the Suppression of Ferroptosis: Mechanistic Insights from In Vivo and In Vitro Models. [PDF]

Int J Mol Sci
Tian Z, Yin Q, Zhou C, Wu X, Liu F, Li J.   +5 more
europepmc   +1 more source

Imaging-guided platform for real-time intervention in complex in vitro models

Serio A, Joshi S, Moreno-Gonzalez C, Suklai P, Carraro E, Ratcliffe C, Boezio G, Konstantinou G, Cano-Ferrer X, Hagemann C, Kavanagh T, Ameer-beg S, Imbert A, Sahai E, Tedesco F.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Engineered In Vitro Disease Models

Annual Review of Pathology: Mechanisms of Disease, 2015
The ultimate goal of most biomedical research is to gain greater insight into mechanisms of human disease or to develop new and improved therapies or diagnostics. Although great advances have been made in terms of developing disease models in animals, such as transgenic mice, many of these models fail to faithfully recapitulate the human condition.
Hyun Jung Kim, Kyung-Jin Jang, Kambez Hajipouran Benam   +2 more
exaly   +3 more sources